Alterity Therapeutics (PRNAD) Free Cash Flow (2009 - 2020)

Alterity Therapeutics (PRNAD) has reported Free Cash Flow for 9 consecutive years, with -$6.2 million the latest figure, recorded in Q2 2020.

• In Q2 2020, Free Cash Flow rose 36.76% year-over-year to -$6.2 million; the TTM figure through Dec 2021 stood at -$6.2 million (up 56.42% YoY), while the FY2025 annual figure was -$7.3 million, up 11.76% from the prior year.
• Free Cash Flow came in at -$6.2 million for Q2 2020 at Alterity Therapeutics, down from $1.8 million in the prior quarter.
• The five-year high for Free Cash Flow was $1.8 million in Q4 2019, with the low at -$9.8 million in Q2 2019.
• Average Free Cash Flow over 5 years is -$3.4 million, with a median of -$4.4 million recorded in 2017.
• The largest YoY upside for Free Cash Flow was 134.21% in 2019 against a maximum downside of 20575.33% in 2019.
• Year by year, Free Cash Flow stood at -$449190.3 in 2016, then sank by 100.19% to -$899256.0 in 2017, then plunged by 475.87% to -$5.2 million in 2018, then jumped by 134.21% to $1.8 million in 2019, then plunged by 448.91% to -$6.2 million in 2020.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$6.2 million, $1.8 million, and -$9.8 million for Q2 2020, Q4 2019, and Q2 2019 respectively.